Toll-like receptor activity in patients with obstructive sleep apnea

Sleep and Breathing

Volumn 17, Issue 3, 2013, Pages 1009-1016

  Akinnusi, Morohunfolu ^a,b   Jaoude, Philippe ^b   Kufel, Thomas ^a,b   El Solh, Ali A ^a,b,c  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Atherosclerosis; CPAP; Cytokines; Nuclear factor B; Obstructive sleep apnea; Toll like receptors

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; HUMAN; INNATE IMMUNITY; MIDDLE AGED; MONOCYTE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEP DISORDERED BREATHING; WAIST HIP RATIO;

ADULT; ATHEROSCLEROSIS; CONTINUOUS POSITIVE AIRWAY PRESSURE; CYTOKINES; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; POLYMERASE CHAIN REACTION; POLYSOMNOGRAPHY; SIGNAL TRANSDUCTION; SLEEP APNEA, OBSTRUCTIVE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84892992784     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-012-0791-2     Document Type: Article

References (46)

1. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP (2010) Pathophysiology of sleep apnea. Physiol Rev 90 (1):47-112
2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (17):1230-1235
3. Redline S, Kump K, Tishler PV, Browner I, Ferrette V (1994) Gender differences in sleep disordered breathing in a communitybased sample. Am J Respir Crit Care Med 149 (3 Pt 1):722-726
4. Strohl KP, Redline S (1996) Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 154 (2 Pt 1):279-289
5. Shah NA, Yaggi HK, Concato J, Mohsenin V (2010) Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath 14 (2):131-136
6. Levy P, Tamisier R, Minville C, Launois S, Pepin JL (2011) Sleep apnoea syndrome in 2011: current concepts and future directions. Eur Respir Rev Off J Eur Respir Soc 20 (121):134-146
7. Li H, Sun B (2007) Toll-like receptor 4 in atherosclerosis. J Cell Mol Med 11 (1):88-95
8. Mullick AE, Tobias PS, Curtiss LK (2006) Toll-like receptors and atherosclerosis: key contributors in disease and health? Immunol Res 34 (3):193-209. doi:10.1385/IR:34:3:193
9. Michelsen KS, Doherty TM, Shah PK, Arditi M (2004) TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 173 (10):5901-5907
10. Takeda K, Akira S (2001) Roles of Toll-like receptors in innate immune responses. Genes Cells Devoted Mol Cell Mech 6 (9):733-742
11. Stoll LL, Denning GM, Weintraub NL (2006) Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. Curr Pharm Des 12 (32):4229-4245
12. Methe H, Kim JO, Kofler S, Weis M, Nabauer M, Koglin J (2005) Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation 111 (20):2654- 2661
13. den Dekker WK, Cheng C, Pasterkamp G, Duckers HJ (2010) Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis 209 (2):314-320
14. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101 (29):10679-10684
15. Liu X, Ukai T, Yumoto H, Davey M, Goswami S, Gibson FC 3rd, Genco CA (2008) Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis 196 (1):146-154
16. Mullick AE, Tobias PS, Curtiss LK (2005) Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 115 (11):3149-3156
17. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, FreemanMW (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10 (4):416-421
18. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165 (7):934-939
19. Dyugovskaya L, Lavie P, Lavie L (2003) Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168 (2):242-249
20. Akinnusi ME, Paasch LL, Szarpa KR, Wallace PK, El Solh AA (2009) Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Respiration 77 (1):25-31
21. Guasti L, Marino F, Cosentino M, Maroni L, Maresca AM, Colombo F, Maio RC, Castiglioni L, Saporiti F, Loraschi A, Gaudio G, Bernasconi A, Laurita E, Grandi AM, Venco A (2011) Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea. Sleep Breath 15 (1):3-11
22. Akinnusi ME, Laporta R, El-Solh AA (2011) Lectin-like oxidized low-density lipoprotein receptor-1 modulates endothelial apoptosis in obstructive sleep apnea. Chest 140 (6):1503-1510
23. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA (2008) Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 4 (2):157-171
24. Rechtschaffen AKA (ed) (1968) A manual of standardized terminology, techniques and scoring system of sleep stages of human subjects. US Government Printing Office, Washington, DC
25. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147 (4):887-895
26. Xu J, Wu Y, He L, Yang Y, Moore SA, Hsu CY (1997) Regulation of cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells. Biochem Biophys Res Commun 235 (2):394-397
27. Dyugovskaya L, Lavie P, HirshM, Lavie L (2005)Activated CD8+ Tlymphocytes in obstructive sleep apnoea. Eur Respir J 25 (5):820-828
28. Constantinidis J, Ereliadis S, Angouridakis N, Konstantinidis I, Vital V, Angouridaki C (2008) Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol 265 (10):1275-1279
29. Lavie L (2003) Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7 (1):35-51
30. Quercioli A, Mach F, Montecucco F (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 14 (3):261-269
31. Kim SY, Choi YJ, Joung SM, Lee BH, Jung YS, Lee JY (2010) Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology 129 (4):516-524
32. Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK (2007) Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2 (12):e1364
33. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, Kelly RA (1999) Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104 (3):271-280
34. Frantz S, Kelly RA, Bourcier T (2001) Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem 276 (7):5197-5203
35. Selejan S, Poss J, Walter F, Hohl M, Kaiser R, Kazakov A, Bohm M, Link A (2012) Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock. Eur Heart J 33 (9):1085-1094
36. Shalhoub J, Falck-Hansen MA, Davies AH, Monaco C (2011) Innate immunity and monocyte-macrophage activation in atherosclerosis. J Inflamm (Lond) 8:9
37. Kuwahata S, Fujita S, Orihara K, Hamasaki S, Oba R, Hirai H, Nagata K, Ishida S, Kataoka T, Oketani N, Ichiki H, Iriki Y, Saihara K, Okui H, Ninomiya Y, Tei C (2010) High expression level of Toll-like receptor 2 on monocytes is an important risk factor for arteriosclerotic disease. Atherosclerosis 209 (1):248-254
38. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (8):1129-1134
39. Teramoto S, Yamamoto H, Ouchi Y (2003) Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 107 (5):E40-40
40. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M (2001) Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 166 (3):2018-2024
41. Hadley JS, Wang JE, Foster SJ, Thiemermann C, Hinds CJ (2005) Peptidoglycan of Staphylococcus aureus upregulates monocyte expression of CD14, Toll-like receptor 2 (TLR2), and TLR4 in human blood: possible implications for priming of lipopolysaccharide signaling. Infect Immun 73 (11):7613-7619
42. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA (1997) Role of nuclear factor-kappa B in atherogenesis. Exp Physiol 82 (2):297-304
43. Zhai Y, Shen XD, O'Connell R, Gao F, Lassman C, Busuttil RW, Cheng G, Kupiec-Weglinski JW (2004) Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173 (12):7115-7119
44. Wu HS, Zhang JX, Wang L, Tian Y, Wang H, Rotstein O (2004) Tolllike receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int: HBPD INT 3 (2):250-253
45. Lavie L, Dyugovskaya L, Golan-Shany O, Lavie P (2010) Heatshock protein 70: expression in monocytes of patients with sleep apnoea and association with oxidative stress and tumour necrosis factor-alpha. J Sleep Res 19 (1 Pt 2):139-147
46. Wu KM, Lin CC, Chiu CH, Liaw SF (2010) Effect of treatment by nasal continuous positive airway pressure on serum high mobility group box-1 protein in obstructive sleep apnea. Chest 137 (2):303-309